Magnitude of Coagulation Abnormalities and Associated Factors Among Patients with Heart Diseases at the University of Gondar Comprehensive Specialized Hospital

Melak Aynalem, Tiruneh Adane, Solomon Getawa Department of Hematology and Immunohematology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaCorrespondence: Solomon Getawa, Department of Hematology and Immunohematology, Scho...

Full description

Bibliographic Details
Main Authors: Aynalem M, Adane T, Getawa S
Format: Article
Language:English
Published: Dove Medical Press 2022-08-01
Series:Vascular Health and Risk Management
Subjects:
Online Access:https://www.dovepress.com/magnitude-of-coagulation-abnormalities-and-associated-factors-among-pa-peer-reviewed-fulltext-article-VHRM
_version_ 1818505074401345536
author Aynalem M
Adane T
Getawa S
author_facet Aynalem M
Adane T
Getawa S
author_sort Aynalem M
collection DOAJ
description Melak Aynalem, Tiruneh Adane, Solomon Getawa Department of Hematology and Immunohematology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaCorrespondence: Solomon Getawa, Department of Hematology and Immunohematology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, P.O. Box: 196, Gondar, Ethiopia, Tel +251-914-665-736, Email solomon2525geta@gmail.comBackground: Heart disease is a leading cause of hospitalization, death, and poor physical function due to comorbid conditions such as atrial fibrillation and stroke. It affects the blood hemostatic system, vasculature, and flow dynamics, causing both arterial and venous thrombosis. Thus, this study aimed to determine the magnitude of coagulation abnormalities among patients with heart disease attending the University of Gondar Comprehensive Specialized hospital.Methods: A cross-sectional study was conducted on a total of 98 patients with heart disease. Pretested structured questionnaires were used to collect data on socio-demographic and clinical variables. About 6 mL of venous blood was collected with the vacutainer method and analyzed using Huma cue-due plus and Sysmex KX-21N hematology analyzers for assessing coagulation abnormalities. Stool samples were processed via a direct wet mount. Thin and thick blood films were examined to assess malaria parasites. Data was entered into EPI-Info version 3.5.3 and then transported to SPSS version 20 for analysis. Descriptive statistics were summarized using frequency and percentage. Univariate and multivariate logistic regression models were fitted to identify factors associated with coagulopathy. P-value < 0.05 was considered to be statistically significant.Results: The overall magnitude of coagulation abnormalities (thrombocytopenia, prolonged prothrombin time, and activated partial thromboplastin time) in patients with heart diseases was 85.7% (95% CI: 81.96, 89.45). Besides, prolonged prothrombin time, prolonged activated partial thromboplastin time, and thrombocytopenia were detected in 83.7%, 33.7%, and 12.2% of the study participants, respectively. Participants who are taking medications for chronic disease (AOR = 0.17; 95% CI: 0.04, 0.69), participants with stroke (AOR = 20; 95% CI: 14.7, 35), and participants taking antibiotics (AOR = 8.17; 95% CI: 1.66, 40.27) were significantly associated with prolonged coagulation time.Conclusion: This study showed that patients with heart disease had prolonged prothrombin time, activated partial thromboplastin time, and thrombocytopenia. Therefore, coagulation parameters are required to be checked regularly to monitor coagulation disorders and their complications in heart disease patients.Keywords: heart diseases, coagulation abnormalities, cardiovascular diseases, Gondar, Ethiopia
first_indexed 2024-12-10T21:45:47Z
format Article
id doaj.art-824016ee7c084256b3c23b03660910ad
institution Directory Open Access Journal
issn 1178-2048
language English
last_indexed 2024-12-10T21:45:47Z
publishDate 2022-08-01
publisher Dove Medical Press
record_format Article
series Vascular Health and Risk Management
spelling doaj.art-824016ee7c084256b3c23b03660910ad2022-12-22T01:32:23ZengDove Medical PressVascular Health and Risk Management1178-20482022-08-01Volume 1861762777113Magnitude of Coagulation Abnormalities and Associated Factors Among Patients with Heart Diseases at the University of Gondar Comprehensive Specialized HospitalAynalem MAdane TGetawa SMelak Aynalem, Tiruneh Adane, Solomon Getawa Department of Hematology and Immunohematology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaCorrespondence: Solomon Getawa, Department of Hematology and Immunohematology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, P.O. Box: 196, Gondar, Ethiopia, Tel +251-914-665-736, Email solomon2525geta@gmail.comBackground: Heart disease is a leading cause of hospitalization, death, and poor physical function due to comorbid conditions such as atrial fibrillation and stroke. It affects the blood hemostatic system, vasculature, and flow dynamics, causing both arterial and venous thrombosis. Thus, this study aimed to determine the magnitude of coagulation abnormalities among patients with heart disease attending the University of Gondar Comprehensive Specialized hospital.Methods: A cross-sectional study was conducted on a total of 98 patients with heart disease. Pretested structured questionnaires were used to collect data on socio-demographic and clinical variables. About 6 mL of venous blood was collected with the vacutainer method and analyzed using Huma cue-due plus and Sysmex KX-21N hematology analyzers for assessing coagulation abnormalities. Stool samples were processed via a direct wet mount. Thin and thick blood films were examined to assess malaria parasites. Data was entered into EPI-Info version 3.5.3 and then transported to SPSS version 20 for analysis. Descriptive statistics were summarized using frequency and percentage. Univariate and multivariate logistic regression models were fitted to identify factors associated with coagulopathy. P-value < 0.05 was considered to be statistically significant.Results: The overall magnitude of coagulation abnormalities (thrombocytopenia, prolonged prothrombin time, and activated partial thromboplastin time) in patients with heart diseases was 85.7% (95% CI: 81.96, 89.45). Besides, prolonged prothrombin time, prolonged activated partial thromboplastin time, and thrombocytopenia were detected in 83.7%, 33.7%, and 12.2% of the study participants, respectively. Participants who are taking medications for chronic disease (AOR = 0.17; 95% CI: 0.04, 0.69), participants with stroke (AOR = 20; 95% CI: 14.7, 35), and participants taking antibiotics (AOR = 8.17; 95% CI: 1.66, 40.27) were significantly associated with prolonged coagulation time.Conclusion: This study showed that patients with heart disease had prolonged prothrombin time, activated partial thromboplastin time, and thrombocytopenia. Therefore, coagulation parameters are required to be checked regularly to monitor coagulation disorders and their complications in heart disease patients.Keywords: heart diseases, coagulation abnormalities, cardiovascular diseases, Gondar, Ethiopiahttps://www.dovepress.com/magnitude-of-coagulation-abnormalities-and-associated-factors-among-pa-peer-reviewed-fulltext-article-VHRMheart diseasescoagulation abnormalitiescardiovascular diseasesgondarethiopia
spellingShingle Aynalem M
Adane T
Getawa S
Magnitude of Coagulation Abnormalities and Associated Factors Among Patients with Heart Diseases at the University of Gondar Comprehensive Specialized Hospital
Vascular Health and Risk Management
heart diseases
coagulation abnormalities
cardiovascular diseases
gondar
ethiopia
title Magnitude of Coagulation Abnormalities and Associated Factors Among Patients with Heart Diseases at the University of Gondar Comprehensive Specialized Hospital
title_full Magnitude of Coagulation Abnormalities and Associated Factors Among Patients with Heart Diseases at the University of Gondar Comprehensive Specialized Hospital
title_fullStr Magnitude of Coagulation Abnormalities and Associated Factors Among Patients with Heart Diseases at the University of Gondar Comprehensive Specialized Hospital
title_full_unstemmed Magnitude of Coagulation Abnormalities and Associated Factors Among Patients with Heart Diseases at the University of Gondar Comprehensive Specialized Hospital
title_short Magnitude of Coagulation Abnormalities and Associated Factors Among Patients with Heart Diseases at the University of Gondar Comprehensive Specialized Hospital
title_sort magnitude of coagulation abnormalities and associated factors among patients with heart diseases at the university of gondar comprehensive specialized hospital
topic heart diseases
coagulation abnormalities
cardiovascular diseases
gondar
ethiopia
url https://www.dovepress.com/magnitude-of-coagulation-abnormalities-and-associated-factors-among-pa-peer-reviewed-fulltext-article-VHRM
work_keys_str_mv AT aynalemm magnitudeofcoagulationabnormalitiesandassociatedfactorsamongpatientswithheartdiseasesattheuniversityofgondarcomprehensivespecializedhospital
AT adanet magnitudeofcoagulationabnormalitiesandassociatedfactorsamongpatientswithheartdiseasesattheuniversityofgondarcomprehensivespecializedhospital
AT getawas magnitudeofcoagulationabnormalitiesandassociatedfactorsamongpatientswithheartdiseasesattheuniversityofgondarcomprehensivespecializedhospital